openPR Logo
Press release

Anticonvulsant Market for Fibromyalgia – Global Industry Demand, Growth, Prize and Business Forecast by 2025

07-07-2017 03:50 PM CET | Health & Medicine

Press release from: TMR Research

Anticonvulsant Market for Fibromyalgia – Global Industry

Anticonvulsant Market for Fibromyalgia: Snapshot

Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons when a person gets seizures. Anticonvulsants also keep the seizure within the brain from spreading to other areas. Anticonvulsants are used extensively for the treatment of fibromyalgia and are thus, expected to be in continued demand during the period from 2017 to 2025. The growing incidences of epilepsy and need for managing pain due to migraines, and rising cases of fibromyalgia worldwide will boost the global anticonvulsants market for fibromyalgia in the coming years.

The report takes into account all the leading factors boosting the growth of the market. It also studies the definition, causes, prevention methods, and treatment options that are available for fibromyalgia. Fibromyalgia causes pain all over the body. The patient also experiences tender points in different parts of the body such as neck, back, hips, arms, shoulders, and legs, when pressure is applied. Thus, the need for effective treatment options for the treatment of this painful disorder will boost the growth of the global anticonvulsants market for fibromyalgia in the coming years.

Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=488

Global Anticonvulsant Market for Fibromyalgia: Overview

The global market for anticonvulsants used for fibromyalgia demonstrates a massive potential for future growth. The efficiency of anticonvulsants in the treatment of various neurological disorders, specifically fibromyalgia, is likely to increase their popularity, reflecting greatly on their demand over the forthcoming years.

The increasing prevalence of fibromyalgia, boosted substantially by the ever-rising base of geriatric population and the increasing expenditure on healthcare, thanks to the augmented disposable income of people have been acting as the key factors driving this market and are expected to maintain its growth pace in the near future too.

Global Anticonvulsant Market for Fibromyalgia: Drivers and Restrains

Currently, a number of both, patented and off-label anticonvulsant drugs, are being used in the treatment of fibromyalgia. Although with expired patents, Topiramate, levetiracetam, divalproex sodium, lamotrigine, oxcarbazepine, and carbamazepine are driving the global market for anticonvulsants used for the treatment of fibromyalgia considerably. In addition, a robust pipeline of anticonvulsants drugs is waiting for U.S. FDA approval, which, post approval, is expected to add significantly to this market in the years to come. The rising preference for generic products is also projected to influence this market remarkably over the next few years.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=488

On the other hand, the stringent regulatory guidelines for the approval of drugs may create obstacles in the growth trajectory of this market to some extent. However, the advancement in medical and healthcare infrastructure in emerging economies is likely to normalize their effects on this market in the near future.

Global Anticonvulsant Market for Fibromyalgia: Geographical Analysis

The global market for anticonvulsants used for fibromyalgia registers its presence across Asia Pacific, Europe, North America, and the Rest of the World. Due to the presence of a large pool of established players, North America has acquired the leading position in this market. The high disposable income of consumers that enables them to afford expensive treatments, is likely to maintain the growth pace of the North America market for anticonvulsants for fibromyalgia over the next few years. Apart from this, the growing awareness among consumers regarding health and wellness and the rising number of neurological disorders are also expected to further drive this market.

Asia Pacific, on the other hand, is anticipated to offer the most promising opportunities for the growth of the worldwide market for anticonvulsants used for fibromyalgia in the near future. The improvement in economic conditions, rise in purchasing power, and the increase in the living standard of people in Asian countries, such as India and China, are likely to boost this regional market over the years to come. The substantial progress in the medical tourism industry in this region is also projected to reflect positively on the demand for anticonvulsants in Asia Pacific in the near future.

Read Comprehensive Overview of Report@ https://www.tmrresearch.com/anticonvulsant-market

Global Anticonvulsant Market for Fibromyalgia: Companies Mentioned in the Report

Pfizer Inc., GlaxoSmithKline Inc., UCB Group, Novartis AG, Johnson & Johnson (J&J), and Abbott Laboratories are some of the leading players operating in the global market for anticonvulsants used for fibromyalgia.

About TMR Research :

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

Rohit Bhisey
Head - Internet Marketing
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anticonvulsant Market for Fibromyalgia – Global Industry Demand, Growth, Prize and Business Forecast by 2025 here

News-ID: 613583 • Views:

More Releases from TMR Research

Automotive Vision System Market Share and Growth Factors Impact Analysis 2021 - 2031
Automotive Vision System Market Share and Growth Factors Impact Analysis 2021 - …
Automotive Vision System Market: Introduction A system that increases the vehicle driver's perception during night or bad weather conditions is termed as Automotive night vision system (ANVS). The system is otherwise beyond the reach of the vehicle's headlights, thereby prevents accidents at night. It can also be defined as a system which assists the driver by increasing visibility during bad whether while providing safety. Vehicle which have automotive vision system integrated are
Waste Heat Recovery Market Competitive Landscape Analysis with Forecast by 2031
Waste Heat Recovery Market Competitive Landscape Analysis with Forecast by 2031
Waste Heat Recovery Market: Snapshot The waste heat recovery market has been expected to reach a valuation of US$ 65.87 Bn and expand at a CAGR of 6.90% in the foreseeable years from 2020 to 2030. The growth opportunities in the waste heat recovery market are attributed to the increasing prices of electricity and energy in the emerging economies. In addition to this, government regulations and incentives are also estimated to contribute
Physical Fitness Equipment Market Current Trends and Future Aspect Analysis | Market has been expected to reach a valuation of US$ 14.8 Bn and expand at a CAGR of 3.3% in the foreseeable years from 2021 to 2031.
Physical Fitness Equipment Market Current Trends and Future Aspect Analysis | Ma …
Global Physical Fitness Equipment Market: Snapshot The physical fitness equipment market has been expected to reach a valuation of US$ 14.8 Bn and expand at a CAGR of 3.3% in the foreseeable years from 2020 to 2030. The revenue generation opportunities in the physical fitness equipment market are attributed to the increasing enthusiasm among people toward fitness. In recent years, the fitness industry has been growing at a noticeable speed owing to
Molecular Spectrometry Market Competitive Analysis and Forecast 2021-2031 | Growing Regions like North America, Europe and Asia Pacific.
Molecular Spectrometry Market Competitive Analysis and Forecast 2021-2031 | Grow …
Global Molecular Spectrometry Market: Snapshot  Molecular spectrometry examines and quantifies the response of molecules on interaction with known amounts of energy. Molecules have some energy levels that can be studied by determining the molecule's energy exchange through emission or absorbance. Molecular spectrometry involves studying emission, absorption, or scattering of electromagnetic waves by atoms or molecules to quantitatively and qualitatively study atoms, molecules or physical processes. The interaction of matter with radiation

All 5 Releases


More Releases for Anticonvulsant

Impact of COVID-19 on Benzodiazepine Anticonvulsant Drugs Market
Benzodiazepine anticonvulsant drugs are effective in preventing or controlling seizures or convulsions. Various types of gamma-amino-butyric acid-A (GABA-A) receptor subtypes are enhanced by the action of benzodiazepines. Different subtypes of benzodiazepines have different effects due to difference in their affinity. According to a research study, α-1-GABA-A, one of the GABA-A subtypes, is responsible for moderating sedation, amnesia, and anticonvulsant activity. α-2-GABA-A, another subtype, moderates anxiety. Benzodiazepine anticonvulsant drugs have high
Anticonvulsant Market for Fibromyalgia Competitive Analysis and Forecast 2017-20 …
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsant are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons
Anticonvulsant Market Steady pace Witnessed over 2025
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons
Anticonvulsant Market for Fibromyalgia Optimistic Opportunities 2025
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons
Anticonvulsant Market : Industry Outlook Analysis Report 2017 - 2025
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons
Anticonvulsant Market Outlook to 2025 Update 2017
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons